Search filters

List of works by Brit Mollenhauer

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

scientific article

A Practical Guide to Immunoassay Method Validation

scientific article

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease

scientific article

A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations

scientific article

Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort.

scientific article published on 30 June 2017

Affective and cognitive Theory of Mind in patients with parkinson's disease

scientific article published on 9 June 2010

Age, drugs, or disease: What alters the macrostructure of sleep in Parkinson’s disease? ⬇️

scientific article published on July 28, 2012

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

scientific article

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

scientific article published on 14 June 2016

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study

scientific article published on 13 November 2018

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease

scientific article published on 19 April 2016

Associated factors for REM sleep behavior disorder in Parkinson disease ⬇️

scientific article published on August 10, 2011

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

scientific article

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease

scientific article

Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.

scientific article published on 4 December 2017

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort

scientific article published on 6 October 2017

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

scientific article published in August 2003

Biobanking of CSF: international standardization to optimize biomarker development

scientific article published on 02 January 2014

Biochemical premotor biomarkers for Parkinson's disease ⬇️

scientific article published on April 15, 2012

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

scientific article published on 10 October 2015

Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials

scientific article published in October 2010

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Biomarkers in biological fluids for dementia with Lewy bodies

scientific article

Blood-based neurochemical diagnosis of vascular dementia: a pilot study

scientific article published on 27 July 2007

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

scientific article published on 6 April 2006

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease

scientific article published in January 2011

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

scientific article published on 28 March 2016

CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies

scientific article

Can we prevent and slow down neurodegeneration with diet and exercise?

scientific article published on 21 December 2015

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease

scientific article published on 18 August 2017

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

scientific article published on August 2016

Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease

scientific article published on 08 February 2017

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

scientific article published on 27 October 2017

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

scientific article

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

scientific article

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias

scientific article published on 7 December 2010

Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease

scientific article

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

scientific article published on 20 August 2016

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study

scientific article published on 20 December 2013

Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study

scientific article published on 19 February 2020

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

scientific article published on 3 May 2017

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia

scientific article

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease

scientific article published on 14 January 2009

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

scientific article published in March 2016

Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder

scientific article published on 01 October 2020

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease

scientific article

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

scientific article published on 3 September 2012

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

scientific article published on 5 December 2016

Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid ⬇️

scientific article published on March 23, 2012

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

scientific article

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

scientific article published on 24 January 2012

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits

scientific article

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

scientific article

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.

scientific article published on 26 August 2017

Erratum to: Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease

scholarly article published in Journal of Neural Transmission

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

scientific article published on 25 August 2016

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation

scientific article

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)

scholarly article by Lana M Chahine et al published 2018 in Journal of Parkinson's disease

Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies

scientific article published on 12 February 2020

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

scientific article

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

scholarly article

GBA variants in REM sleep behavior disorder: a multicenter study

scientific article published on 26 June 2020

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

scientific article

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types

scientific article published on 18 October 2014

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)

Improved preparation of nasal lavage fluid (NLF) as a noninvasive sample for proteomic biomarker discovery

scientific article published on 10 February 2015

Increased CSF biomarkers of angiogenesis in Parkinson disease.

scientific article

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies

scientific article published on 8 December 2015

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine.

scientific article

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder

scientific article published on 21 March 2018

Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions

scientific article

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.

scientific article published on 13 October 2017

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort

scientific article published on 23 March 2018

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

scientific article

Metabolic profiling of body fluids and multivariate data analysis

scientific article

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

scientific article published on 3 November 2015

MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity ⬇️

scientific article published on April 4, 2012

Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress

scientific article published on 14 December 2016

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

scientific article

Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration

scientific article published on 29 September 2016

Mutations in VPS26A are not a frequent cause of Parkinson's disease.

scientific article

Neurochemical biomarkers in the differential diagnosis of movement disorders

scientific article published on July 2009

Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders

scientific article (publication date: 2013)

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

scholarly article by Franziska Hopfner et al published 2019 in Translational Neurodegeneration

Non-Motor Correlates of Smoking Habits in de Novo Parkinson's Disease

scientific article published on 19 October 2015

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

scientific article

Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease

scientific article published on 2 November 2005

Novel Associations of <i>BST1</i> and <i>LAMP3</i> with Rapid Eye Movement Sleep Behavior Disorder

scientific article published on 04 January 2021

Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening ⬇️

scientific article published on July 27, 2012

Parkinson's disease biomarkers based on α-synuclein

scientific article published on 28 July 2019

Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)

scholarly article by Monika Balzer-Geldsetzer et al published 2011 in Neuroepidemiology

Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy

scientific article published on 21 October 2008

Prediagnostic presentation of Parkinson's disease in primary care: A case-control study

scientific article published on 16 April 2015

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned

scientific article

Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

scientific article published on 26 October 2006

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)

scholarly article by Yuliya Stankevich et al published October 2018 in American Journal of Geriatric Psychiatry

Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD.

scientific article published on 11 July 2015

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

scientific article published on October 2010

Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?

scientific article published on January 2014

REM Sleep Behavioral Events and Dreaming

scientific article published on 15 April 2015

REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations

scientific article published on 15 March 2015

Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?

scientific article published on March 2014

Rare variants in LRRK1 and Parkinson's disease

scientific article

Rare variants in PLXNA4 and Parkinson's disease

scientific article

Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease

scientific article

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

scientific article published on August 2012

Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases

scientific article published in April 2010

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease

scientific article published on 7 September 2015

SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder

scientific article published on 18 April 2020

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies

scientific article

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study

scientific article published on 8 July 2016

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

scientific article published on 5 January 2005

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

scientific article

The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease

scientific article published on 9 June 2016

The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease.

scientific article published in March 2018

The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease

scientific article published on 29 March 2017

The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker

scientific article published on 10 March 2017

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

scientific article published on 26 August 2017

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases ⬇️

scientific article published on May 6, 2011

The role ofSCARB2as susceptibility factor in Parkinson's disease

scholarly article by Franziska Hopfner et al published 13 February 2013 in Movement Disorders

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

scientific article published on 28 August 2015

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies

scientific article published in January 2006

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

scientific article published on 25 September 2013

Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid

scientific article published on 10 August 2015

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

scientific article published on 15 May 2015

Validation of conversion between mini-mental state examination and montreal cognitive assessment

scientific article

Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid

scientific article published on 15 May 2017

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease

scientific article published on 21 March 2017

Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease

scientific article published on 16 June 2012

What can biomarkers tell us about cognition in Parkinson's disease?

scientific article published on April 2014

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

scientific article published on March 2011

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system

scientific article

Paulina is supported by:

About Paulina

Help